{"id":"https://openalex.org/W4401904841","doi":"https://doi.org/10.33380/2305-2066-2024-13-3-1771","title":"Development and validation of the method of quantification of 5-[5-(trifluoromethyl)-1,2-oxazole-3-yl]-furan-2-sulfonamide and its metabolites in laboratory animal plasma","display_name":"Development and validation of the method of quantification of 5-[5-(trifluoromethyl)-1,2-oxazole-3-yl]-furan-2-sulfonamide and its metabolites in laboratory animal plasma","publication_year":2024,"publication_date":"2024-08-27","ids":{"openalex":"https://openalex.org/W4401904841","doi":"https://doi.org/10.33380/2305-2066-2024-13-3-1771"},"language":"en","primary_location":{"id":"doi:10.33380/2305-2066-2024-13-3-1771","doi":"https://doi.org/10.33380/2305-2066-2024-13-3-1771","is_oa":true,"landing_page_url":"https://doi.org/10.33380/2305-2066-2024-13-3-1771","pdf_url":"https://www.pharmjournal.ru/jour/article/download/1917/1315","source":{"id":"https://openalex.org/S4210178334","display_name":"Drug development & registration","issn_l":"2305-2066","issn":["2305-2066","2658-5049"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug development & registration","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.pharmjournal.ru/jour/article/download/1917/1315","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013538960","display_name":"\u042f\u0438\u0447\u043a\u043e\u0432 \u0418\u043b\u044c\u044f \u0418\u0433\u043e\u0440\u0435\u0432\u0438\u0447","orcid":"https://orcid.org/0000-0002-0066-7388","observed_orcids":["https://orcid.org/0000-0002-0066-7388"]},"institutions":[{"id":"https://openalex.org/I4210121576","display_name":"Yaroslavl State Pedagogical University","ror":"https://ror.org/02n3d5p55","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210121576"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"I. I. Yaichkov","raw_affiliation_strings":["Yaroslavl State Pedagogical University named after K. D. Ushinsky. M. V. Dorogov Pharmaceutical Technology Transfer Center; Federal State Budgetary Educational Institution of Higher Education \"Yaroslavl State Medical University\" of the Ministry of Healthcare of the Russian Federation"],"raw_orcid":"https://orcid.org/0000-0002-0066-7388","affiliations":[{"raw_affiliation_string":"Yaroslavl State Pedagogical University named after K. D. Ushinsky. M. V. Dorogov Pharmaceutical Technology Transfer Center; Federal State Budgetary Educational Institution of Higher Education \"Yaroslavl State Medical University\" of the Ministry of Healthcare of the Russian Federation","institution_ids":["https://openalex.org/I4210121576"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050245122","display_name":"Mikhail K. Korsakov","orcid":"https://orcid.org/0000-0003-0913-2571","observed_orcids":["https://orcid.org/0000-0003-0913-2571"]},"institutions":[{"id":"https://openalex.org/I4210121576","display_name":"Yaroslavl State Pedagogical University","ror":"https://ror.org/02n3d5p55","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210121576"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"M. K. Korsakov","raw_affiliation_strings":["Yaroslavl State Pedagogical University named after K. D. Ushinsky. M. V. Dorogov Pharmaceutical Technology Transfer Center"],"raw_orcid":"https://orcid.org/0000-0003-0913-2571","affiliations":[{"raw_affiliation_string":"Yaroslavl State Pedagogical University named after K. D. Ushinsky. M. V. Dorogov Pharmaceutical Technology Transfer Center","institution_ids":["https://openalex.org/I4210121576"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044473159","display_name":"\u0410\u043d\u0442\u043e\u043d \u0410. \u0428\u0435\u0442\u043d\u0435\u0432","orcid":"https://orcid.org/0000-0002-4389-461X","observed_orcids":["https://orcid.org/0000-0002-4389-461X"]},"institutions":[{"id":"https://openalex.org/I4210121576","display_name":"Yaroslavl State Pedagogical University","ror":"https://ror.org/02n3d5p55","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210121576"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A. A. Shetnev","raw_affiliation_strings":["Yaroslavl State Pedagogical University named after K. D. Ushinsky. M. V. Dorogov Pharmaceutical Technology Transfer Center"],"raw_orcid":"https://orcid.org/0000-0002-4389-461X","affiliations":[{"raw_affiliation_string":"Yaroslavl State Pedagogical University named after K. D. Ushinsky. M. V. Dorogov Pharmaceutical Technology Transfer Center","institution_ids":["https://openalex.org/I4210121576"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026489459","display_name":"\u0412\u043e\u043b\u044c\u0445\u0438\u043d \u041d\u0438\u043a\u0438\u0442\u0430 \u041d\u0438\u043a\u043e\u043b\u0430\u0435\u0432\u0438\u0447","orcid":"https://orcid.org/0000-0002-4275-9037","observed_orcids":["https://orcid.org/0000-0002-4275-9037"]},"institutions":[{"id":"https://openalex.org/I4210121576","display_name":"Yaroslavl State Pedagogical University","ror":"https://ror.org/02n3d5p55","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210121576"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"N. N. Volkhin","raw_affiliation_strings":["Yaroslavl State Pedagogical University named after K. D. Ushinsky. M. V. Dorogov Pharmaceutical Technology Transfer Center"],"raw_orcid":"https://orcid.org/0000-0002-4275-9037","affiliations":[{"raw_affiliation_string":"Yaroslavl State Pedagogical University named after K. D. Ushinsky. M. V. Dorogov Pharmaceutical Technology Transfer Center","institution_ids":["https://openalex.org/I4210121576"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074689251","display_name":"\u041f\u0435\u0442\u0443\u0445\u043e\u0432 \u0421\u0435\u0440\u0433\u0435\u0439 \u0421\u0442\u0430\u043d\u0438\u0441\u043b\u0430\u0432\u043e\u0432\u0438\u0447","orcid":"https://orcid.org/0009-0007-8435-7689","observed_orcids":["https://orcid.org/0009-0007-8435-7689"]},"institutions":[{"id":"https://openalex.org/I4210121576","display_name":"Yaroslavl State Pedagogical University","ror":"https://ror.org/02n3d5p55","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210121576"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"S. S. Petukhov","raw_affiliation_strings":["Yaroslavl State Pedagogical University named after K. D. Ushinsky. M. V. Dorogov Pharmaceutical Technology Transfer Center; Federal State Budgetary Educational Institution of Higher Education \"Yaroslavl State Medical University\" of the Ministry of Healthcare of the Russian Federation"],"raw_orcid":"https://orcid.org/0009-0007-8435-7689","affiliations":[{"raw_affiliation_string":"Yaroslavl State Pedagogical University named after K. D. Ushinsky. M. V. Dorogov Pharmaceutical Technology Transfer Center; Federal State Budgetary Educational Institution of Higher Education \"Yaroslavl State Medical University\" of the Ministry of Healthcare of the Russian Federation","institution_ids":["https://openalex.org/I4210121576"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210121576"],"apc_list":null,"apc_paid":null,"fwci":0.2522,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.33478518,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carbonic-anhydrase-ii-inhibitors","display_name":"carbonic anhydrase II inhibitors","score":0.8989999890327454},{"id":"https://openalex.org/keywords/open-angle-glaucoma","display_name":"open-angle glaucoma","score":0.9350000023841858},{"id":"https://openalex.org/keywords/plasma-drug-quantitation","display_name":"plasma drug quantification","score":0.8349999785423279},{"id":"https://openalex.org/keywords/hplc-ms-ms-method-validation","display_name":"HPLC-MS/MS method validation","score":0.8690000176429749},{"id":"https://openalex.org/keywords/rat-plasma","display_name":"rat plasma","score":0.6039999723434448},{"id":"https://openalex.org/keywords/rabbit-plasma","display_name":"rabbit plasma","score":0.8240000009536743},{"id":"https://openalex.org/keywords/systemic-exposure","display_name":"systemic exposure","score":0.36800000071525574}],"concepts":[{"id":"https://openalex.org/C2778203186","wikidata":"https://www.wikidata.org/wiki/Q413437","display_name":"Oxazole","level":2,"score":0.8281787037849426},{"id":"https://openalex.org/C2781039511","wikidata":"https://www.wikidata.org/wiki/Q3208529","display_name":"Sulfonamide","level":2,"score":0.8050957918167114},{"id":"https://openalex.org/C2776442012","wikidata":"https://www.wikidata.org/wiki/Q2302144","display_name":"Trifluoromethyl","level":3,"score":0.7208639979362488},{"id":"https://openalex.org/C2778659115","wikidata":"https://www.wikidata.org/wiki/Q243992","display_name":"Furan","level":2,"score":0.6332042813301086},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5170907974243164},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.44257649779319763},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.25578218698501587},{"id":"https://openalex.org/C2780263894","wikidata":"https://www.wikidata.org/wiki/Q335268","display_name":"Alkyl","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.33380/2305-2066-2024-13-3-1771","doi":"https://doi.org/10.33380/2305-2066-2024-13-3-1771","is_oa":true,"landing_page_url":"https://doi.org/10.33380/2305-2066-2024-13-3-1771","pdf_url":"https://www.pharmjournal.ru/jour/article/download/1917/1315","source":{"id":"https://openalex.org/S4210178334","display_name":"Drug development & registration","issn_l":"2305-2066","issn":["2305-2066","2658-5049"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug development & registration","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:52838cbd2d95414faabcc41820fa7e0e","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/52838cbd2d95414faabcc41820fa7e0e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"\u0420\u0430\u0437\u0440\u0430\u0431\u043e\u0442\u043a\u0430 \u0438 \u0440\u0435\u0433\u0438\u0441\u0442\u0440\u0430\u0446\u0438\u044f \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u044b\u0445 \u0441\u0440\u0435\u0434\u0441\u0442\u0432, Vol 13, Iss 3, Pp 219-230 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.33380/2305-2066-2024-13-3-1771","doi":"https://doi.org/10.33380/2305-2066-2024-13-3-1771","is_oa":true,"landing_page_url":"https://doi.org/10.33380/2305-2066-2024-13-3-1771","pdf_url":"https://www.pharmjournal.ru/jour/article/download/1917/1315","source":{"id":"https://openalex.org/S4210178334","display_name":"Drug development & registration","issn_l":"2305-2066","issn":["2305-2066","2658-5049"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug development & registration","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4401904841.pdf","grobid_xml":"https://content.openalex.org/works/W4401904841.grobid-xml"},"referenced_works_count":9,"referenced_works":["https://openalex.org/W2624020525","https://openalex.org/W3115892211","https://openalex.org/W3155487168","https://openalex.org/W3159463257","https://openalex.org/W4205202774","https://openalex.org/W4210803997","https://openalex.org/W4384662518","https://openalex.org/W4388930839","https://openalex.org/W4393395671"],"related_works":["https://openalex.org/W4400332589","https://openalex.org/W4388930839","https://openalex.org/W4393395671","https://openalex.org/W4404590865","https://openalex.org/W7217103706","https://openalex.org/W2355635391","https://openalex.org/W4379232317","https://openalex.org/W1963909623","https://openalex.org/W7153678265","https://openalex.org/W1980180158"],"abstract_inverted_index":{"Introduction.":[0],"The":[1,132,205,266,278,302,322,342,368],"study":[2,212,376],"of":[3,7,16,32,40,52,64,67,70,112,130,134,184,213,219,286,305,307,325,332,356,365,377,382],"the":[4,30,37,50,118,196,362,383],"systemic":[5],"exposure":[6],"a":[8,22,65,174,179,210,214],"new":[9,23],"original":[10],"drug":[11],"is":[12,21],"an":[13,104,143],"essential":[14],"part":[15],"its":[17,44,73,351,359],"preclinical":[18],"study.":[19],"5-[5-(trifluoromethyl)-1,2-oxazole-3-yl]-furan-2-sulfonamide":[20,71,220,308,357],"selective":[24],"carbonic":[25],"anhydrase":[26],"II":[27],"inhibitor":[28],"for":[29,36,97,271,338,353,374],"treatment":[31],"open-angle":[33],"glaucoma.":[34],"Methods":[35],"quantitative":[38,68,354],"determination":[39,69,306,355],"this":[41],"compound":[42],"and":[43,46,62,72,77,82,89,137,187,276,291,327,349,358],"N-hydroxy-":[45],"N-acetyl":[47],"metabolites":[48,74,360],"in":[49,80,195,202,284,309,335,361],"plasma":[51,85,119,310,333,364],"laboratory":[53,366],"animals":[54],"have":[55],"not":[56],"been":[57,282,346,371],"previously":[58],"developed.":[59],"Aim.":[60],"Development":[61],"validation":[63],"method":[66,206,280,344,369],"N-hydroxy-5-[5-(trifluoromethyl)-1,2-oxazole-3-yl]-furan-2-sulfonamide":[75],"(M1)":[76],"N-acetyl-5-[5-(trifluoromethyl)-1,2-oxazole-3-yl]-furan-2-sulfonamide":[78],"(M2)":[79],"rat":[81],"rabbit":[83],"blood":[84,363],"by":[86,93],"HPLC-MS/MS.":[87],"Materials":[88],"methods.":[90],"Protein":[91],"precipitation":[92],"methanol":[94],"was":[95,101,115,140,147,192,207,269,311],"applied":[96],"sample":[98],"preparation.":[99],"5-[2-(morpholine-4-carbonyl)-1,3-oxazole-5-yl]-thiophene-2-sulfonamide":[100],"used":[102,270,373],"as":[103,142,231,233],"internal":[105],"standard.":[106],"A":[107],"5":[108],"%":[109,181,216,379],"aqueous":[110,182],"solution":[111,183,329],"ascorbic":[113],"acid":[114,186],"added":[116],"to":[117,127],"samples":[120,226,334],"at":[121],"volume":[122],"ratio":[123],"1":[124,215,236,238,378],":":[125],"2":[126,242],"prevent":[128],"decomposition":[129],"N-hydroxy-5-[5-(trifluoromethyl)-1,2-oxazole-3-yl]-furan-2-sulfonamide.":[131],"combination":[133,324],"sodium":[135],"fluoride":[136],"potassium":[138],"oxalate":[139],"selected":[141,323],"anticoagulant.":[144],"Chromatographic":[145],"separation":[146],"performed":[148],"on":[149,178,221],"Zorbax":[150,162],"Eclipse":[151,163],"Plus":[152,164],"C18":[153,165],"column":[154],"(150":[155],"\u00d7":[156,168],"3.0":[157],"mm,":[158,170],"3.5":[159],"\u00b5m)":[160,172],"with":[161],"pre-column":[166],"(12.5":[167],"2.1":[169],"5.0":[171],"using":[173,199],"mobile":[175],"phase":[176],"based":[177],"0.1":[180],"formic":[185],"methanol.":[188],"Mass":[189],"spectrometric":[190],"detection":[191],"carried":[193],"out":[194],"MRM":[197],"mode":[198],"electrospray":[200],"ionization":[201],"negative":[203],"polarity.":[204],"tested":[208],"during":[209],"pharmacokinetic":[211,273,375],"ocular":[217,380],"suspension":[218,381],"6":[222,248],"Wistar":[223],"rats.":[224],"Blood":[225],"were":[227],"collected":[228],"before":[229],"administration,":[230],"well":[232],"30":[234,240],"min,":[235,241],"h,":[237,243,245,247,249,251,253,255,257,259,261],"h":[239,263],"3":[244],"4":[246],"8":[250],"12":[252],"24":[254],"48":[256],"72":[258],"144":[260],"216":[262],"after":[264],"administration.":[265],"non-compartment":[267],"approach":[268],"calculation":[272],"parameters.":[274],"Results":[275],"discussion.":[277],"developed":[279,343],"has":[281,345,370],"validated":[283,348],"parameters":[285],"selectivity,":[287],"calibration":[288],"curve,":[289],"accuracy":[290],"precision,":[292],"matrix":[293],"effect,":[294],"dilution":[295],"integrity,":[296],"carry":[297],"over,":[298],"reinjection":[299],"reproducibility,":[300],"stability.":[301],"analytical":[303],"range":[304],"10\u20134000":[312],"ng/ml,":[313,317],"M1":[314],"\u2013":[315,319],"1.0\u2013400.0":[316],"M2":[318],"0.1\u201340.0":[320],"ng/ml.":[321],"anticoagulant":[326],"stabilizer":[328],"allows":[330],"storage":[331],"freezing":[336],"chamber":[337],"28":[339],"days.":[340],"Conclusion.":[341],"fully":[347],"confirmed":[350],"suitability":[352],"animals.":[367],"successfully":[372],"drug.":[384]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2024-08-28T00:00:00"}